With the rise of molecular biology, target-based drug discovery has gradually become the mainstream model of new drug development. Targets and binding sites of target-receptor interactions are usually obtained by structural biology methods. Target structures and binding sites are used as models for virtual screening, and the potential binding molecules are obtained through high-throughput screening methods.

https://www.creative-biostructure.com/cryo-em.htm

Creative Biostructure is specialized in providing contract services to both academia and biotech/pharmaceutical industries in the field of structural biology.

We offer insightful strategies and cost-effective services on structure determination of macromolecules using X-ray Crystallography, EM, NMR, etc.